Pharmafile Logo

Pharma-Exclusive Webinar: Redefining Engagement in the AI Era

Join Impetus Digital’s pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static programs into high-retention, interactive experiences without enterprise overhead.

- PMLiVE

 

While artificial intelligence has generated endless conversation across life sciences, moving from theoretical promise to practical execution remains a major hurdle for many teams. Designed specifically to cut through the industry noise, this pharma-exclusive webinar reveals how forward-thinking Medical Affairs, Med Ed, and Commercial leaders are deploying fully compliant, low-friction AI tools and interactive virtual workflows without incurring enterprise overhead or navigating complex open-web security risks.

Attendees will discover how to elevate static presentations and traditional learning modules into dynamic, high-retention environments—utilizing interactive AI presenters, dynamic scenario branching, and conversational AI peers like Ruby to transform passive participants into active, high-retention collaborators. Beyond showcasing creative, multi-departmental use cases and real-world client workflows, the session breaks down how to capture real-time market intelligence straight from live analytics dashboards—surfacing instant audience confidence scores, clinical knowledge gaps, and trending questions. Ultimately, this masterclass demystifies the adoption process, equipping agile life science teams with actionable best practices to boost knowledge retention by 4x, optimize project budgets, and achieve high-velocity outcomes.


Click here to learn more and register

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events…

Leadership Lessons Learned from the Pandemic

Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health…

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health…

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons…

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma…

Solving the Caregiver Crisis Through Technology

Curtis Khan, CEO and Founder of BookJane, discusses the ongoing caregiver crisis and how BookJane’s solutions and other digital technologies can help to close this gap. We also delve into how…

Therapeutic VR for Managing Pain & Improving Patient Outcomes

Ramsay Brown, CEO and Founder of Quol, delves into several different HealthTech topics, including the concept of VR therapeutics and the importance of incorporating behavioral science and neuroscience into VR solutions, as…

Visual Storytelling in HealthTech

Rodney Hu, founder of 209|Digital and a popular podcast host. We explore Rodney’s work within the HealthTech space and what he believes has to happen for the healthcare industry to more…

Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients

Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to…